熱門資訊> 正文
BioRobotics在CEO退休后被解雇
2025-07-25 23:23
- Shares of Procept BioRobotics (NASDAQ:PRCT) fell ~9% on Friday after the surgical robotics company announced that its CEO, Reza Zadno, would retire effective Sept. 1, and Larry Wood, a member of the board of directors, would succeed him.
- Concurrently, the San Jose, California-based MedTech also preannounced its Q2 2025 results, indicating $79.2M in revenue, which exceeded $76.1M in FactSet consensus.
- Wood joins Procept (NASDAQ:PRCT) on Sept. 2 from Edwards Lifesciences (EW), where he has functioned as corporate vice president and group president at the heart device maker’s Transcatheter Aortic Valve Replacement and Surgical Structural Heart units since 2023.
- “On behalf of the board of directors, I want to thank Reza for his dedication to the Company and its mission over the past five years,” PRCT’s chair, Thomas Prescott, said.
More on Procept
- PROCEPT BioRobotics: A 'Razor And Razor Blade' Business Model
- Seeking Alpha’s Quant Rating on Procept
- Historical earnings data for Procept
- Financial information for Procept
推薦文章
華盛早報 | 降息懸了？美聯儲7月會議僅兩位官員支持降息；港交所將研究24小時交易機制
重磅預期催化！港交所將研究24小時交易機制 券商板塊迎價值重估（附概念股）
美股機會日報 | 今夜凌晨2點！會議紀要將揭露美聯儲內部分歧；塔吉特、雅詩蘭黛績后重挫
華爾街分析師大膽預測：2030年英偉達市值將達9萬億美元，年收入將達6000億美元
意外嗎？英偉達是「最被低配」的大盤科技美股
港股異動 | 兩大新消費「龍頭」業績喜人帶動板塊大漲！泡泡瑪特績后飆漲13%
華盛早報丨漲近24%→跌超20%！東方甄選俞敏洪緊急迴應；光伏再開反內卷會議
8月20日外盤頭條：美國擴大鋼鐵和鋁關税範圍 白宮考慮在布達佩斯舉行俄烏會談 標普維持美國信用評級
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
